Drug Discovery & Pharmaceuticals

RSS

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce the National Institute on Drug Abuse at the National Institutes of Health has awarded Nicholas Cosford, Ph.D., a three-year, $10.8 million grant to pursue the preclinical development of a new class of medicine to treat substance use disorders.

26 Sep 2017

Researchers use multi-modal integrated approach to develop potential anti-Chagas therapies

Chagas disease is a potentially life-threatening illness caused by the parasite, Trypanosoma cruzi, and is transmitted to humans through triatomine blood-sucking bugs that are commonly referred to as "kissing bugs" or "vampire bugs".

26 Sep 2017

Advanced technique could pave way for cascade of new steroidal therapeutics

Researchers at Dartmouth College have developed a technique to produce synthetic steroids that could pave the way for a cascade of new drug discoveries. The process, published in the journal Nature Chemistry, facilitates access to rare, mirror-image isomers of naturally occurring steroid structures.

26 Sep 2017

One-fourth of cancer patients use cannabis, study reveals

New research conducted in a cancer center in a state that had legalized the use of recreational and medicinal cannabis shown that about one-fourth of surveyed cancer patients used cannabis in the previous year, mostly for psychological and physical symptoms. The study also indicated that legalization increased the likelihood of a rise of cannabis use among cancer patients.

25 Sep 2017

New collaboration could lead to novel drugs that address unmet medical needs

Southern Research and the University of Tennessee Health Science Center have formed a partnership to advance promising research that could lead to new drugs that address unmet medical needs.

20 Sep 2017

LSUHealthNO to examine effectiveness of novel drug designed for heart muscle regeneration

In collaboration with Novo Biosciences, Inc., LSU Health New Orleans Cardiovascular Center of Excellence will receive more $500,000 over two years to study the effectiveness of a novel drug designed to stimulate the regeneration of heart muscle and prevent the formation or scar tissue following a heart attack.

15 Sep 2017

Porvair Sciences provide optimised microplate products for drug discovery scientists

Porvair Sciences offers a range of application optimised microplates and high-performance microplate equipment designed to enable drug discovery scientists to optimise sample preparation and improve productivity.

From Porvair Sciences Limited 15 Sep 2017

Pharmaceutical compound from leaves of coralberry may help combat asthma

The coralberry could offer new hope for asthmatics: researchers at the University of Bonn have extracted a new kind of active pharmaceutical ingredient from its leaves to combat this widespread respiratory disease. In mice, it almost completely inhibits the characteristic contraction of the airways.

14 Sep 2017

New discovery by TSRI scientists could speed efforts to develop effective HIV vaccine

Scientists at The Scripps Research Institute have made a discovery that could speed efforts to develop a successful HIV vaccine.

14 Sep 2017

Researchers overcome major stumbling blocks in developing HIV vaccine

An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation long enough to respond to and stop virus infection.

13 Sep 2017

Genestack provides missing link between data and analysis for drug discovery

“Genestack is providing an essential missing link between data and its analysis,” says Imad I. Yassin, recently appointed Vice President of Sales and Marketing for Genestack, the Cambridge-based biodata management company.

13 Sep 2017

Chemists examine radioactive metal complexes for tumor diagnosis and treatment

A team under the direction of chemist Prof. Dr Peter Comba is investigating radioactive metal complexes for use in the diagnosis and treatment of tumors.

12 Sep 2017

VUMC and Bayer agree on strategic research alliance to develop new therapies for kidney diseases

Vanderbilt University Medical Center and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.

12 Sep 2017

Novel compounds found to be highly effective in preventing transmission of malaria parasites

Significant headway has been made in controlling malaria. However, two vexing problems remain: currently available treatments are unable to block transmission of the parasite that causes the disease, and the parasite often becomes resistant to drugs.

7 Sep 2017

Natural compound produced by honeybees could become basis for new antibiotics

An antimicrobial compound made by honeybees could become the basis for new antibiotics, according to new research at the University of Illinois at Chicago.

7 Sep 2017

Researchers synthesizing new, first-in-class drug to stop growth of ER-positive breast cancer

Researchers at UT Health San Antonio and two partner institutions are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive (ER-positive) breast cancer in its tracks.

30 Aug 2017

Researchers develop new approach to efficiently produce versatile antibody therapies

A group of researchers has developed an approach to efficiently produce antibodies that can bind to two different target molecules simultaneously, a long-desired innovation in the field of cancer immunotherapy.

29 Aug 2017

Research may lead to first-ever pharmacological treatment for rare genetic bone disease

Scientists at Children's Hospital of Philadelphia report that a drug candidate that blocks abnormal protein signals may lead to the first pharmacologic treatment for hereditary multiple exostoses (HME), a rare pediatric genetic disease.

29 Aug 2017

Collaborative project reaches milestone halfway point in constructing Kinase Chemogenomic Set

The Structural Genomics Consortium at the University of North Carolina at Chapel Hill (SGC-UNC), in partnership with the DiscoverX Corporation, has reached the milestone halfway point in its development of the Kinase Chemogenomic Set, a potent group of inhibitors which allow deeper exploration of the human kinome, a family of enzymes critical to understanding human disease and developing new therapies.

26 Aug 2017

CSUDH professor seeks novel lead compound to develop new drug for treating cancer

Does anyone have a cardiac pacemaker or medical device implants? How about keys, a mobile phone, or even a wallet? We wouldn't want anything to get damaged or erased."

26 Aug 2017

Drug Discovery & Pharmaceuticals

SBP researcher awarded $10.8 million grant to pursue development of new drug for substance abuse

Researchers use multi-modal integrated approach to develop potential anti-Chagas therapies

Advanced technique could pave way for cascade of new steroidal therapeutics

One-fourth of cancer patients use cannabis, study reveals

New collaboration could lead to novel drugs that address unmet medical needs

LSUHealthNO to examine effectiveness of novel drug designed for heart muscle regeneration

Porvair Sciences provide optimised microplate products for drug discovery scientists

Pharmaceutical compound from leaves of coralberry may help combat asthma

New discovery by TSRI scientists could speed efforts to develop effective HIV vaccine

Researchers overcome major stumbling blocks in developing HIV vaccine

Genestack provides missing link between data and analysis for drug discovery

Chemists examine radioactive metal complexes for tumor diagnosis and treatment

VUMC and Bayer agree on strategic research alliance to develop new therapies for kidney diseases

Novel compounds found to be highly effective in preventing transmission of malaria parasites

Natural compound produced by honeybees could become basis for new antibiotics

Researchers synthesizing new, first-in-class drug to stop growth of ER-positive breast cancer

Researchers develop new approach to efficiently produce versatile antibody therapies

Research may lead to first-ever pharmacological treatment for rare genetic bone disease

Collaborative project reaches milestone halfway point in constructing Kinase Chemogenomic Set

CSUDH professor seeks novel lead compound to develop new drug for treating cancer

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Latest Life Science News